Key result
The rs7404339 AA genotype in CDH5 significantly increased the risk of Kawasaki disease susceptibility compared to the GG genotype (adjusted OR 1.43).
Why the study?
The pathogenesis of Kawasaki disease remains unclear and the relationship between CDH5 polymorphisms and Kawasaki disease susceptibility had not been previously reported.
Does the rs7404339 AA genotype in CDH5 increase the risk of Kawasaki disease and coronary artery lesions in children?
Case-Control (n=3,004)
No
Does the rs7404339 AA genotype in CDH5 increase the risk of Kawasaki disease and coronary artery lesions in children?
Odds Ratio: 1.43 (95% CI 1–2.05)
Absolute Event Rate: 5.24% vs 3.65%
p-value: p=0.0493
The rs7404339 AA genotype in CDH5 is associated with an increased risk of Kawasaki disease and its complication, coronary artery lesions, in southern Chinese children.
rs7404339 AA genotype may flag higher KD/CAL risk in southern Chinese children; leaves open CDH5's causal role in endothelial dysfunction.
Background Kawasaki disease (KD) is an acute, self-limited febrile illness of unknown cause. And it predominantly affects children <5 years and the main complication is coronary artery lesion (CAL). Studies demonstrated that vascular endothelial cells (VECs) played a very important role in the CAL of KD. VE-cad encoded by CDH5 may exert a relevant role in endothelial cell biology through controlling the cohesion of the intercellular junctions. The pathogenesis of KD remains unclear and genetic factors may increase susceptibility of KD. However, the relationship between CDH5 polymorphisms and KD susceptibility has not been reported before. The present study is aimed at investigating whether the rs7404339 polymorphism in CDH5 is associated with KD susceptibility and CAL in a southern Chinese child population. Methods and Results We recruited 1,335 patients with KD and 1,669 healthy children. Each participant had supplied 2 mL of fresh blood in the clinical biologic bank at our hospital for other studies. Multiplex PCR is used to assess the genotypes of rs7404339 polymorphism in CDH5. According to the results, we found significant correlated relationship between rs7404339 polymorphism in CDH5 and KD susceptibility [AA vs. GG: adjusted odds ratio (OR) = 1.43, 95% confidence interval (CI) = 1.00–2.05; p = 0.0493; recessive model: adjusted OR = 1.44, 95% CI = 1.01–2.06, P = 0.0431]. In further stratified analysis, we found that children younger than 60 months (adjusted OR = 1.46, 95% CI = 1.01–2.10; p = 0.0424) and male (adjusted OR = 1.70, 95% CI = 1.09–2.65; p = 0.0203) with the rs7404339 AA genotype in CDH5 had a higher risk of KD than carriers of the GA/GG genotype. Furthermore, stratification analysis revealed that patients with the rs7404339 AA genotype exhibited the significantly higher onset risk for CAL than carriers of the GA/GG genotype (adjusted age and gender odds ratio = 1.56, 95% CI = 1.01–2.41; P = 0.0433). Conclusion Our results showed that rs7404339 AA genotype in CDH5 is significant associated with KD susceptibility. And children younger than 60 months and male with the rs7404339 AA genotype had a higher risk of KD than carriers with the GA/GG genotype. Furthermore, patients with the rs7404339 AA genotype exhibited a significantly higher risk of CAL complication than carriers of the GA/GG genotype.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a case-control in Kawasaki disease (n=3,004). rs7404339 AA genotype in CDH5 vs. GG genotype was evaluated on Kawasaki disease susceptibility (OR 1.43, 95% CI 1.00-2.05, p=0.0493). The rs7404339 AA genotype in CDH5 significantly increased the risk of Kawasaki disease susceptibility compared to the GG genotype (adjusted OR 1.43).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: